The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study
- PMID: 10406604
- DOI: 10.1016/s0161-6420(99)00707-1
The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study
Abstract
Objective: To compare the visual outcome of traumatic optic neuropathy treated with corticosteroids, treated with optic canal decompression surgery, or observed without treatment.
Design: Comparative nonrandomized interventional study with concurrent treatment groups.
Participants: A total of 133 patients with traumatic optic neuropathy (127 unilateral and 6 bilateral) who had an initial visual assessment within 3 days of injury. At least 1 month of follow-up was required for inclusion in the primary analysis.
Interventions: On the basis of treatment received within 7 days of injury, patients with unilateral injuries were categorized as being in one of three treatment groups: untreated (n = 9), corticosteroid (n = 85), or optic canal decompression surgery (n = 33).
Main outcome measure: Visual acuity.
Results: Visual acuity increased by > or = 3 lines in 32% of the surgery group, 57% of the untreated group, and 52% of the steroid group (P = 0.22). The surgery group had more patients whose initial vision was no light perception. After adjustment for the baseline visual acuity, there were no significant differences between any of the treatment groups. There was no indication that the dosage or timing of corticosteroid treatment or the timing of surgery was associated with an increased probability of visual improvement.
Conclusions: No clear benefit was found for either corticosteroid therapy or optic canal decompression surgery. The number of patients studied was sufficient to rule out major effects in the treatment groups, although clinically relevant effects in specific subgroups could have been missed. These results and the existing literature provide sufficient evidence to conclude that neither corticosteroids nor optic canal surgery should be considered the standard of care for patients with traumatic optic neuropathy. It is therefore clinically reasonable to decide to treat or not treat on an individual patient basis.
Comment in
-
Traumatic optic neuropathy.Ophthalmology. 2000 May;107(5):814. doi: 10.1016/s0161-6420(99)00164-5. Ophthalmology. 2000. PMID: 10811061 No abstract available.
Similar articles
-
Traumatic optic neuropathy.Ophthalmology. 2000 May;107(5):814. doi: 10.1016/s0161-6420(99)00164-5. Ophthalmology. 2000. PMID: 10811061 No abstract available.
-
The effect of steroids in combination with optic nerve decompression surgery in traumatic optic neuropathy.Laryngoscope. 2013 May;123(5):1082-6. doi: 10.1002/lary.23845. Epub 2013 Apr 2. Laryngoscope. 2013. PMID: 23553638
-
Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy.Eur J Ophthalmol. 2002 Jul-Aug;12(4):309-14. doi: 10.1177/112067210201200410. Eur J Ophthalmol. 2002. PMID: 12220002
-
[Traumatic optic neuropathy: Report of 8 cases and review of the literature].J Fr Ophtalmol. 2016 Sep;39(7):603-8. doi: 10.1016/j.jfo.2016.05.007. Epub 2016 Aug 24. J Fr Ophtalmol. 2016. PMID: 27566879 Review. French.
-
Treatment of traumatic optic neuropathy.Int Ophthalmol Clin. 1999 Winter;39(1):185-94. doi: 10.1097/00004397-199903910-00017. Int Ophthalmol Clin. 1999. PMID: 10083916 Review. No abstract available.
Cited by
-
Optic Neuropathy with Delayed Onset After Trauma: Case Report and Review of the Literature.Neuroophthalmology. 2016;40(4):188-191. doi: 10.1080/01658107.2016.1177091. Epub 2016 May 16. Neuroophthalmology. 2016. PMID: 27570324 Free PMC article.
-
Traumatic Optic Nerve Injury Elevates Plasma Biomarkers of Traumatic Brain Injury in a Porcine Model.J Neurotrauma. 2021 Apr 15;38(8):1000-1005. doi: 10.1089/neu.2020.7039. Epub 2020 Nov 18. J Neurotrauma. 2021. PMID: 33096971 Free PMC article.
-
Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study.Graefes Arch Clin Exp Ophthalmol. 2011 May;249(5):731-6. doi: 10.1007/s00417-010-1534-3. Epub 2010 Oct 2. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 20890611
-
RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2470-2477. doi: 10.1167/iovs.18-24096. Invest Ophthalmol Vis Sci. 2018. PMID: 29847652 Free PMC article.
-
Optic Nerve Decompression through a Supraorbital Approach.J Neurol Surg B Skull Base. 2015 Jun;76(3):239-47. doi: 10.1055/s-0034-1543964. Epub 2015 Jan 21. J Neurol Surg B Skull Base. 2015. PMID: 26225308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical